e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ProShares Ultra Nasdaq Biotechnology
(NQ:
BIB
)
82.76
UNCHANGED
Streaming Delayed Price
Updated: 4:15 PM EST, Dec 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
82.76
Bid (Size)
80.61 (100)
Ask (Size)
89.50 (300)
Prev. Close
82.76
Today's Range
82.76 - 82.76
52wk Range
33.77 - 84.34
Shares Outstanding
N/A
Dividend Yield
0.87%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
How Abivax Went From Biotech Nobody To M&A Bullseye After A Single Blockbuster Readout This Year
↗
Today 4:01 EST
A 1,900% rally, Phase 3 wins, and takeover chatter around Eli Lilly have transformed Abivax from a risky clinical bet into a strategic asset with real optionality.
Via
Stocktwits
Artiva Biotherapeutics Gets A Price Target Hike From Wedbush: Stock Rallies 99% But Retail Expects Further Rally
↗
October 17, 2025
Wedbush’s new price target implies a whopping 730% potential upside to the stock’s closing price on Thursday.
Via
Stocktwits
Performance
YTD
+61.2%
+61.2%
1 Month
+3.5%
+3.5%
3 Month
+42.6%
+42.6%
6 Month
+77.2%
+77.2%
1 Year
+59.5%
+59.5%
More News
Read More
Pharma Tariffs Back In Spotlight On New Trump Threat
↗
September 26, 2025
Via
Investor's Business Daily
Topics
ETFs
Government
World Trade
Donald Trump Is Finally Making Good On Pharma Tariffs Threats, But Stocks Yawn
↗
July 16, 2025
Via
Investor's Business Daily
Topics
ETFs
Government
World Trade
Friday Trades And June Summary
↗
July 03, 2021
Via
Talk Markets
Trump Threatens To Slam Pharmaceuticals With Up To 200% Tariffs
↗
July 08, 2025
Via
Investor's Business Daily
Topics
ETFs
Economy
Government
Lifeline For 23andMe? Stock Jumps After Court Greenlights Bankruptcy Asset Sale, Retail Weighs Possible Rescue Deals
↗
March 28, 2025
Via
Stocktwits
Topics
Bankruptcy
Tonix Pharma Dominates Retail Biotech Buzz After 1-for-100 Reverse Split, Sentiment Turns Neutral Amid Volatility
↗
February 05, 2025
Via
Stocktwits
Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding
↗
January 29, 2025
Via
Stocktwits
Amgen, Inc. Dividend Stock Analysis
↗
July 05, 2024
Via
Talk Markets
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
↗
March 25, 2024
Via
InvestorPlace
The 7 Best ETFs to Buy to Cover 2023’s Biggest Investing Opportunities
↗
December 20, 2022
Via
InvestorPlace
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
↗
December 18, 2022
Via
InvestorPlace
Market Briefing For Tuesday, July 5, 2022
↗
July 04, 2022
Via
Talk Markets
Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index
↗
December 17, 2021
Via
Benzinga
Take A Look At The Top-Performing Biotech ETFs YTD
↗
October 02, 2021
Via
Talk Markets
Frequently Asked Questions
Is ProShares Ultra Nasdaq Biotechnology publicly traded?
Yes, ProShares Ultra Nasdaq Biotechnology is publicly traded.
What exchange does ProShares Ultra Nasdaq Biotechnology trade on?
ProShares Ultra Nasdaq Biotechnology trades on the Nasdaq Stock Market
What is the ticker symbol for ProShares Ultra Nasdaq Biotechnology?
The ticker symbol for ProShares Ultra Nasdaq Biotechnology is BIB on the Nasdaq Stock Market
What is the current price of ProShares Ultra Nasdaq Biotechnology?
The current price of ProShares Ultra Nasdaq Biotechnology is 82.76
When was ProShares Ultra Nasdaq Biotechnology last traded?
The last trade of ProShares Ultra Nasdaq Biotechnology was at 12/23/25 04:15 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.